These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1963641)

  • 1. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
    Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
    J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B.
    Ashton AC; Dolly JO
    J Neurochem; 1991 Mar; 56(3):827-35. PubMed ID: 1847184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
    Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
    J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
    Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
    Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
    Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
    J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
    Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
    Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction.
    Katz E; Protti DA; Ferro PA; Rosato Siri MD; Uchitel OD
    Br J Pharmacol; 1997 Aug; 121(8):1531-40. PubMed ID: 9283685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A targets RhoB to inhibit lysophosphatidic acid-stimulated actin reorganization and acetylcholine release in nerve growth factor-treated PC12 cells.
    Ishida H; Zhang X; Erickson K; Ray P
    J Pharmacol Exp Ther; 2004 Sep; 310(3):881-9. PubMed ID: 15140914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
    Fernández-Salas E; Ho H; Garay P; Steward LE; Aoki KR
    Mov Disord; 2004 Mar; 19 Suppl 8():S23-34. PubMed ID: 15027051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions.
    Molgo J; Comella JX; Angaut-Petit D; Pecot-Dechavassine M; Tabti N; Faille L; Mallart A; Thesleff S
    J Physiol (Paris); 1990; 84(2):152-66. PubMed ID: 2290130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin and dendrotoxin as probes for studies on transmitter release.
    Dolly JO; Halliwell JV; Black JD; Williams RS; Pelchen-Matthews A; Breeze AL; Mehraban F; Othman IB; Black AR
    J Physiol (Paris); 1984; 79(4):280-303. PubMed ID: 6152294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-ribosylation of cerebrocortical synaptosomal proteins by cholera, pertussis and botulinum toxins.
    Ashton AC; Edwards K; Dolly JO
    Toxicon; 1990; 28(8):963-73. PubMed ID: 1981953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2(+)-dependent noradrenaline release from permeabilised PC12 cells is blocked by botulinum neurotoxin A or its light chain.
    McInnes C; Dolly JO
    FEBS Lett; 1990 Feb; 261(2):323-6. PubMed ID: 2311761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External pH changes affect NMDA-evoked and spontaneous release of cholecystokinin, somatostatin and noradrenaline from rat cerebrocortical nerve endings.
    Gemignani A; Paudice P; Longordo F; Raiteri M
    Neurochem Int; 2004 Oct; 45(5):677-85. PubMed ID: 15234110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
    Poulain B; Wadsworth JD; Maisey EA; Shone CC; Melling J; Tauc L; Dolly JO
    Eur J Biochem; 1989 Oct; 185(1):197-203. PubMed ID: 2572418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.
    Dolly JO; Wang J; Zurawski TH; Meng J
    FEBS J; 2011 Dec; 278(23):4454-66. PubMed ID: 21645262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of botulinum A toxin and tetanus toxin on synaptic transmission.
    Dreyer F; Becker C; Bigalke H; Funk J; Penner R; Rosenberg F; Ziegler M
    J Physiol (Paris); 1984; 79(4):252-8. PubMed ID: 6152293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.